Cargando…
Optimal antithrombotic therapy after transcatheter aortic valve replacement in patients with atrial fibrillation
Atrial fibrillation (AF) is prevalent in patients with aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR). Depending on the timing of AF detection, it is usually categorized as pre-existing AF or new-onset AF. Antiplatelet therapy, rather than a vitamin K antagonist, may b...
Autores principales: | Zeng, Qingchun, Cheng, Zhendong, Xia, Yi, Cheng, Rui, Ou, Ailian, Li, Xinrui, Xu, Xingbo, Huang, Yuli, Xu, Dingli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576914/ https://www.ncbi.nlm.nih.gov/pubmed/33133475 http://dx.doi.org/10.1177/2040622320949068 |
Ejemplares similares
-
Efficacy and safety of antithrombotic therapy with non-vitamin K
antagonist oral anticoagulants after transcatheter aortic valve replacement: a
systematic review and meta-analysis
por: An, Qing, et al.
Publicado: (2021) -
Antithrombotic Therapy in Transcatheter Aortic Valve Replacement
por: Valvo, Roberto, et al.
Publicado: (2019) -
Antithrombotic Therapy Following Transcatheter Aortic Valve Replacement
por: Granger, Camille, et al.
Publicado: (2022) -
Antithrombotic Therapy after Transcatheter Aortic Valve Replacement
por: Mousa, Tariq A. M., et al.
Publicado: (2022) -
Antithrombotic therapy in patients undergoing transcatheter aortic valve replacement
por: Han, Yaling
Publicado: (2022)